Systematic review of the efficacy, effectiveness and safety of MF59<sup>®</sup> adjuvanted seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

Éamon Ó Murchú(Trinity College Dublin), Patricia Harrington(Health and Safety Authority), Marta Soler Soneira(Instituto de Salud Carlos III), AnnaSara Carnahan(Swedish Institute), Ole Wichmann(Robert Koch Institute), Conor Teljeur(Health and Safety Authority), Ioanna D. Pavlopoulou(National and Kapodistrian University of Athens), Pasi Penttinen(European Centre for Disease Prevention and Control), Hanna Nohynek(Finnish Institute for Health and Welfare), Tyra Grove Krause(Statens Serum Institut), Laura Comber(Health and Safety Authority), Nathalie Nicolay(European Centre for Disease Prevention and Control), Karen Jordan(Health and Safety Authority), Máirín Ryan(University College Dublin), Richard Pebody(National Security Agency), Jørgen de Jonge(National Institute for Public Health and the Environment), Kari Johansen(European Centre for Disease Prevention and Control), Michelle O’Neill(Health and Safety Authority), Liam E. Marshall(Northwood University), Sarah Hawkshaw(Health and Safety Authority), Jaime Jesús Pérez(Instituto Murciano de Investigación Biosanitaria), Anna Hayman Robertson(Norwegian Institute of Public Health)
Reviews in Medical Virology
February 10, 2022
Cited by 20


Related Papers